Awareness of Nonalcoholic Fatty Liver Disease Is Increasing but Remains Very Low in a Representative US Cohort

Abstract

Background

Nonalcoholic fatty liver disease (NAFLD) has become the most common form of chronic liver disease in the USA. Interestingly, most patients with NAFLD are unaware of having any liver disease (LD). We aimed to assess the awareness of suspected NAFLD and factors associated with being aware of LD.

Methods

Adult subjects with suspected NAFLD (BMI > 25) with elevated ALT in the absence of secondary causes of LD who participated in the continuous national health and nutrition examination survey (NHANES) during 2001–2016 were identified and analyzed. Trends of NAFLD awareness were then assessed in periods of 4 years each. Multivariable logistic regression analysis was performed to assess factors associated with LD awareness.

Results

A total of 7033 subjects were included in the final analysis (1731, 1757, 1711, and 1834 subjects for the periods of 2001–2004, 2005–2008, 2009–2012, and 2013–2016, respectively). Over the study duration, an increase in BMI, waist circumference, diabetes, and HbA1c; and a decrease in the number of smokers, platelets count, bilirubin, total cholesterol, and LDL level were noticed (p < 0.001). Awareness of having LD across study periods has increased over time from 1.5% in the 2001–2004 periods to 3.1% in the 2013–2016 periods. Multivariable logistic regression analysis showed that older age, ethnicity (non-black), having fewer drinks/week, metabolic syndrome, higher ALT, ALP, and GGT were associated with being aware of having LD.

Conclusions

Awareness of having LD among subjects with suspected NAFLD has increased over the last two decades, but more than 95% of these patients are still unaware of having LD. Educational programs to increase awareness of LD and risk factors for NAFLD should be implemented on a large scale.

Clinical Trial Registration Number

Not required, as we used de-identified NHANES data.

This is a preview of subscription content, log in to check access.

Fig. 1

Abbreviations

AF:

Advanced fibrosis

AST:

Aspartate aminotransferase

ALT:

Alanine aminotransferase

APRI:

AST to platelet ration index

BMI:

Body mass index

CDC:

Centers for disease control and prevention

ESLD:

End-stage liver disease

FIB-4:

Fibrosis-4

GGT:

γ-Glutamyl transpeptidase

HSI:

Hepatic steatosis index

HDL:

High-density lipoprotein

HbA1c:

Hemoglobin A1c

IDF:

International diabetes federation

LDL:

Low-density lipoprotein

LD:

Liver disease

MCQ:

“Medical conditions” questionnaire

MetS:

Metabolic syndrome

NHANES:

National health and nutrition examination survey

NAFLD:

Nonalcoholic fatty liver disease

NFS:

NAFLD fibrosis score

NASH:

Nonalcoholic steatohepatitis

NCHS:

National center for health statistics

ULN:

Upper limit of normal

References

  1. 1.

    Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore, Md).. 2016;64:73–84.

    Article  Google Scholar 

  2. 2.

    Wong RJ, Liu B, Bhuket T. Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011–2014 National Health and Nutrition Examination Survey. Aliment Pharmacol Ther. 2017;46:974–980.

    CAS  Article  Google Scholar 

  3. 3.

    Kabbany MN, Conjeevaram Selvakumar PK, Watt K, et al. Prevalence of nonalcoholic steatohepatitis-associated cirrhosis in the United States: an analysis of national health and nutrition examination survey data. Am J Gastroenterol. 2017;112:581–587.

    Article  Google Scholar 

  4. 4.

    Noureddin M, Vipani A, Bresee C, et al. NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances. Am J Gastroenterol. 2018;113:1649–1659.

    Article  Google Scholar 

  5. 5.

    Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844–1850.

    CAS  Article  Google Scholar 

  6. 6.

    Wieland AC, Mettler P, McDermott MT, Crane LA, Cicutto LC, Bambha KM. Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk. J Clin Gastroenterol. 2015;49:e6–e10.

    CAS  Article  Google Scholar 

  7. 7.

    Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999–2006. Diabetes Care. 2011;34:216–219.

    Article  Google Scholar 

  8. 8.

    Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113–121.

    Article  Google Scholar 

  9. 9.

    Sanna C, Rosso C, Marietti M, Bugianesi E. Nonalcoholic fatty liver disease and extra-hepatic cancers. Int J Mol Sci. 2016;17:717.

    Article  Google Scholar 

  10. 10.

    Yasui K, Sumida Y, Mori Y, et al. Nonalcoholic steatohepatitis and increased risk of chronic kidney disease. Metab Clin Exp. 2011;60:735–739.

    CAS  Article  Google Scholar 

  11. 11.

    Yan LH, Mu B, Guan Y, et al. Assessment of the relationship between nonalcoholic fatty liver disease and diabetic complications. J Diabetes Investig. 2016;7:889–894.

    CAS  Article  Google Scholar 

  12. 12.

    Leung CM, Lai LS, Wong WH, et al. Nonalcoholic fatty liver disease: an expanding problem with low levels of awareness in Hong Kong. J Gastroenterol Hepatol. 2009;24:1786–1790.

    Article  Google Scholar 

  13. 13.

    Federation ID. The IDF Consensus Worldwide Definition of the Metabolic Syndrome 2011. https://www.pitt.edu/~super1/Metabolic/IDF1.pdf. Accessed 30 Jan 2019.

  14. 14.

    Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis: Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2010;42:503–508.

    CAS  Article  Google Scholar 

  15. 15.

    Johnson CL, Paulose-Ram R, Ogden CL, et al. National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Stat. 2013;2:1–24.

    Google Scholar 

  16. 16.

    Kim D, Kim WR. Nonobese Fatty Liver Disease. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc. 2017;15:474–485.

    CAS  Article  Google Scholar 

  17. 17.

    Yilmaz Y. Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome? World J Hepatol. 2012;4:332–334.

    Article  Google Scholar 

  18. 18.

    Dyson JK, Anstee QM, McPherson S. Nonalcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol. 2014;5:211–218.

    CAS  Article  Google Scholar 

  19. 19.

    Lee MJ, Kim EH, Bae SJ, et al. Age-related decrease in skeletal muscle mass is an independent risk factor for incident nonalcoholic fatty liver disease: a 10-year retrospective cohort study. Gut Liver. 2019;13:67–76.

    Article  Google Scholar 

  20. 20.

    Lazo M, Hernaez R, Eberhardt MS, et al. Prevalence of nonalcoholic fatty liver disease in the United States: the third national health and nutrition examination survey, 1988–1994. Am J Epidemiol. 2013;178:38–45.

    Article  Google Scholar 

  21. 21.

    Coogan PE, Wise LA, Cozier YC, Palmer JR, Rosenberg L. Lifecourse educational status in relation to weight gain in African American women. Ethn Dis. 2012;22:198–206.

    PubMed  PubMed Central  Google Scholar 

  22. 22.

    Bergqvist CJ, Skoien R, Horsfall L, Clouston AD, Jonsson JR, Powell EE. Awareness and opinions of nonalcoholic fatty liver disease by hospital specialists. Intern Med J. 2013;43:247–253.

    Article  Google Scholar 

  23. 23.

    Grattagliano I, D’Ambrosio G, Palmieri VO, et al. Improving nonalcoholic fatty liver disease management by general practitioners: a critical evaluation and impact of an educational training program. J Gastrointestin Liver Dis. 2008;17:389–394.

    PubMed  Google Scholar 

  24. 24.

    Polanco-Briceno S, Glass D, Stuntz M, Caze A. Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists. BMC Res Notes. 2016;9:157.

    Article  Google Scholar 

  25. 25.

    Singh Sp MB, Misra D, Pati GK, et al. Awareness and opinion of nonalcoholic fatty liver disease (NAFLD) patients about obesity and its consequences. J Hepatol. 2014;60:S352.

    Google Scholar 

  26. 26.

    Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, et al. Long term nutritional intake and the risk for nonalcoholic fatty liver disease (NAFLD): a population based study. J Hepatol. 2007;47:711–717.

    CAS  Article  Google Scholar 

  27. 27.

    Singh SP, Singh A, Misra D, et al. Risk factors associated with nonalcoholic fatty liver disease in Indians: a case-control study. J Clin Exp Hepatol. 2015;5:295–302.

    Article  Google Scholar 

  28. 28.

    Modi AA, Feld JJ, Park Y, et al. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology (Baltimore, Md).. 2010;51:201–209.

    CAS  Article  Google Scholar 

  29. 29.

    Kistler KD, Brunt EM, Clark JM, et al. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol. 2011;106:460–468. quiz 469.

    Article  Google Scholar 

  30. 30.

    Goldberg RB, Temprosa M, Haffner S, et al. Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group. Diabetes Care. 2009;32:726–732.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Contributions

AS, ASD, MG, and NA helped in study concept and design; AS contributed to acquisition of data; all authors helped in analysis and interpretation of data, drafting of the manuscript and critical revision of the manuscript for important intellectual content, and administrative, technical, or material support; RL, AS, and NA contributed to statistical analysis; ASD, SS, AK, AK, MN, WC, AM, and NA contributed to study supervision.

Corresponding author

Correspondence to Amandeep Singh.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Singh, A., Dhaliwal, A.S., Singh, S. et al. Awareness of Nonalcoholic Fatty Liver Disease Is Increasing but Remains Very Low in a Representative US Cohort. Dig Dis Sci 65, 978–986 (2020). https://doi.org/10.1007/s10620-019-05700-9

Download citation

Keywords

  • Nonalcoholic fatty liver disease (NAFLD)
  • Noninvasive scores
  • Awareness
  • Liver disease